Funded Tech Companies

Superluminal Medicines

Superluminal Medicines, based in Boston, received equity investments from Eli Lilly and Company, Cooley and Insight Venture Partners.

Company Overview

Contact Information

Company Background Information

Overview

Superluminal Medicines is a generative biology and chemistry company developing a differentiated pipeline and revolutionizing the speed and accuracy of how medicine is created. The company's platform creates candidate-ready compounds with unprecedented speed using a comprehensive combination of deep biology and chemistry expertise, machine learning, and proprietary big data infrastructure.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

9/9/2024

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Cony D'Cruz

        

Company Investors

• Eli Lilly and Company
• Cooley
• Insight Venture Partners
• Catalio Capital Management
• RA Capital Management (Andrew Levin)
• Nventures
• Gaingels
• NVIDIA

Browse more funded tech companies:

Superlogic | Supermaven

Share this article

About Our VC & M&A Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary